CJC-1295 NO DAC specifications and research profile
Specifications summary
| Designation | Supplier-designated no-DAC modified GHRH analogue |
|---|---|
| Also known as | CJC-1295 NO DAC; modified GRF(1-29) |
| Sequence / composition | Modified hGRF(1-29) without the albumin-binding DAC group; verify against COA |
| Strength | 5mg × 10 vials |
| Presentation | 10-vial case |
| Purity | 99%+ HPLC |
| Storage | Store refrigerated at 2-8 C, protected from light. |
| COA | Batch document added when available |
Description and research context
The no-DAC listing denotes a modified hGRF(1-29)-type research material without the albumin-binding Drug Affinity Complex used in long-acting CJC-1295.
It is suited to controlled comparison with native hGRF(1-29) and DAC-modified material in receptor, stability and pituitary-cell assays. The marketed name is not a substitute for batch-level sequence confirmation.
Applications in research
- GHRH-receptor activation assays
- Modified-GRF stability and sequence comparisons
- No-DAC versus albumin-binding analogue studies
Precautions and interpretation
For controlled laboratory research only. Not for human or veterinary use. The cited findings come from specific biochemical, cellular, structural or preclinical models and must not be treated as usage guidance or evidence of a defined outcome outside those models.
Research references
CJC-1295 NO DAC research record
Clear product, batch, storage, dispatch and document information for this 10-vial case.
Research context
A supplier-designated no-DAC GHRH analogue used for laboratory comparison with native hGRF(1-29) and albumin-binding CJC-1295 preparations.
Product record
The listing identifies the presentation, specification, storage record, dispatch status, and COA availability for the relevant product or batch.
Use restriction
For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.